DK524788A - APPLICATION OF MORPHINE ANTAGONISTS FOR THE PREPARATION OF IMMUNO MODULATING AND ANTIVIRAL EFFECTS, IN PARTICULAR FOR TREATMENT OF ACQUIRED IMMUNDEFECT CONDITIONS - Google Patents
APPLICATION OF MORPHINE ANTAGONISTS FOR THE PREPARATION OF IMMUNO MODULATING AND ANTIVIRAL EFFECTS, IN PARTICULAR FOR TREATMENT OF ACQUIRED IMMUNDEFECT CONDITIONSInfo
- Publication number
- DK524788A DK524788A DK524788A DK524788A DK524788A DK 524788 A DK524788 A DK 524788A DK 524788 A DK524788 A DK 524788A DK 524788 A DK524788 A DK 524788A DK 524788 A DK524788 A DK 524788A
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- treatment
- acquired
- immundefect
- conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/35—Corticotropin [ACTH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Utilization of morphine antagonists, such as Naltrexone, beta-endorphine 1-27, or their derivatives or analogs, in the preparation of an immunomodulator and/or antiviral drug for the treatment of acquired immunodeficiency states, particularly the infection by HIV.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8700670A FR2609632B1 (en) | 1987-01-21 | 1987-01-21 | NOVEL THERAPEUTIC APPLICATION OF 17- (CYCLOPROPYLMETHYL) -4,5-EPOXY-3,14-DIHYDROXYMORPHINON-6-ONE AND PHARMACEUTICAL COMPOSITIONS FOR THIS USE |
PCT/FR1988/000032 WO1988005297A1 (en) | 1987-01-21 | 1988-01-21 | Utilization of morphine antagonists in the preparation of drugs having an immunomodulator and antiviral effect, particularly for treating acquired immunodeficiency states |
Publications (2)
Publication Number | Publication Date |
---|---|
DK524788D0 DK524788D0 (en) | 1988-09-21 |
DK524788A true DK524788A (en) | 1988-11-18 |
Family
ID=9347124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK524788A DK524788A (en) | 1987-01-21 | 1988-09-21 | APPLICATION OF MORPHINE ANTAGONISTS FOR THE PREPARATION OF IMMUNO MODULATING AND ANTIVIRAL EFFECTS, IN PARTICULAR FOR TREATMENT OF ACQUIRED IMMUNDEFECT CONDITIONS |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0278821B1 (en) |
JP (1) | JPH02502278A (en) |
AT (1) | ATE112488T1 (en) |
AU (1) | AU610561B2 (en) |
DE (1) | DE3851711D1 (en) |
DK (1) | DK524788A (en) |
FR (1) | FR2609632B1 (en) |
OA (1) | OA09124A (en) |
WO (1) | WO1988005297A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5095035A (en) * | 1981-07-31 | 1992-03-10 | Eby Iii George A | Flavor stable zinc acetate compositions for oral absorption |
US4877791A (en) * | 1988-11-01 | 1989-10-31 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for interestitial cystitis |
US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
US4863928A (en) * | 1989-01-04 | 1989-09-05 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for arthritic and inflammatory diseases |
RU2056852C1 (en) * | 1994-03-18 | 1996-03-27 | Иван Николаевич Головистиков | Agent for treatment of autoimmune diseases with suppressor immunodeficiency and a method of autoimmune diseases treatment |
RU2058553C1 (en) * | 1994-03-18 | 1996-04-20 | Иван Николаевич Головистиков | Method of estimation of human immune status suppressive link |
US6274591B1 (en) | 1997-11-03 | 2001-08-14 | Joseph F. Foss | Use of methylnaltrexone and related compounds |
ATE510534T1 (en) * | 2002-03-14 | 2011-06-15 | Euro Celtique Sa | NALTREXONE HYDROCHLORIDE COMPOSITIONS |
EP2368554B1 (en) | 2003-04-08 | 2014-12-24 | Progenics Pharmaceuticals, Inc. | Pharmaceutical formulations containing methylnaltrexone |
US9662390B2 (en) | 2005-03-07 | 2017-05-30 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
US8518962B2 (en) | 2005-03-07 | 2013-08-27 | The University Of Chicago | Use of opioid antagonists |
US8524731B2 (en) | 2005-03-07 | 2013-09-03 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
US9662325B2 (en) | 2005-03-07 | 2017-05-30 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
AR057035A1 (en) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SYNTHESIS OF (R) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES |
AR057325A1 (en) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | SYNTHESIS OF (S) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES |
MX2009010515A (en) | 2007-03-29 | 2009-10-19 | Wyeth Corp | Peripheral opioid receptor and antagonists and uses thereof. |
PE20130480A1 (en) | 2007-03-29 | 2013-05-08 | Progenics Pharm Inc | HETEROCYCLIC COMPOUNDS AS ANTAGONISTS OF THE PERIPHERAL OPIOID RECEPTOR |
EP3263571B2 (en) | 2007-03-29 | 2023-08-23 | Progenics Pharmaceuticals, Inc. | Crystal form of (r)-n-methylnaltrexone bromide and uses thereof |
CA2713568C (en) | 2008-02-06 | 2016-09-20 | Progenics Pharmaceuticals, Inc. | Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone |
EP2278966B1 (en) | 2008-03-21 | 2019-10-09 | The University of Chicago | Treatment with opioid antagonists and mtor inhibitors |
CA2676881C (en) | 2008-09-30 | 2017-04-25 | Wyeth | Peripheral opioid receptor antagonists and uses thereof |
EP3416619A2 (en) * | 2016-02-18 | 2018-12-26 | Immune Therapeutics, Inc. | Method for inducing a sustained immune response |
JP2022525126A (en) * | 2019-03-13 | 2022-05-11 | アダミス ファーマシューティカルズ コーポレーション | A preparation containing a combination of β-endorphin and adrenocorticotropic hormone |
US11285192B2 (en) | 2019-03-13 | 2022-03-29 | Adamis Pharmaceuticals Corporation | Formulation including a combination of beta-endorphin and adrenocorticotropic hormone |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3332950A (en) * | 1963-03-23 | 1967-07-25 | Endo Lab | 14-hydroxydihydronormorphinone derivatives |
-
1987
- 1987-01-21 FR FR8700670A patent/FR2609632B1/en not_active Expired - Lifetime
-
1988
- 1988-01-21 AU AU11896/88A patent/AU610561B2/en not_active Ceased
- 1988-01-21 WO PCT/FR1988/000032 patent/WO1988005297A1/en unknown
- 1988-01-21 EP EP88400132A patent/EP0278821B1/en not_active Expired - Lifetime
- 1988-01-21 DE DE3851711T patent/DE3851711D1/en not_active Expired - Lifetime
- 1988-01-21 AT AT88400132T patent/ATE112488T1/en not_active IP Right Cessation
- 1988-01-21 JP JP87506276A patent/JPH02502278A/en active Pending
- 1988-09-21 DK DK524788A patent/DK524788A/en not_active Application Discontinuation
-
1989
- 1989-07-20 OA OA59616A patent/OA09124A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU610561B2 (en) | 1991-05-23 |
ATE112488T1 (en) | 1994-10-15 |
AU1189688A (en) | 1988-08-10 |
EP0278821A1 (en) | 1988-08-17 |
DK524788D0 (en) | 1988-09-21 |
EP0278821B1 (en) | 1994-10-05 |
DE3851711D1 (en) | 1994-11-10 |
FR2609632A1 (en) | 1988-07-22 |
FR2609632B1 (en) | 1991-03-29 |
JPH02502278A (en) | 1990-07-26 |
WO1988005297A1 (en) | 1988-07-28 |
OA09124A (en) | 1991-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK524788D0 (en) | APPLICATION OF MORPHINE ANTAGONISTS FOR THE PREPARATION OF IMMUNO MODULATING AND ANTIVIRAL EFFECTS, IN PARTICULAR FOR TREATMENT OF ACQUIRED IMMUNDEFECT CONDITIONS | |
DK0509019T3 (en) | Treatment of human retroviral infections with 2 ', 3'-dideoxyinosine | |
DK162965C (en) | APPLICATION OF A DIFLUORNUCLEOSIDE OR A PHARMACEUTICAL ACCEPTABLE SALT THEREOF FOR THE PREPARATION OF A MEDICINE FOR THE TREATMENT OF NEOPLASMA | |
ES2149267T3 (en) | SUBSTITUTED CYCLIC CARBONYLL AND DERIVED FROM THE SAME USEFUL AS RETROVIRAL PROTEASE INHIBITORS. | |
ES2130114T3 (en) | 5,11-DIHIDRO-6H-DIPIRIDO (3,2-B: 2 ', 3'-E) (1,4) DIAZEPINES AND ITS USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION. | |
DK336688A (en) | NUCLEOSIDES WITHOUT PROCEDURE FOR PREPARING THEREOF | |
DK92788A (en) | USE OF 3'-DEOXY-3'-FLUORUANOSIDES FOR THE PREPARATION OF MEDICINAL PRODUCTS AGAINST RETROVIRA | |
ZA913033B (en) | N-(3-fluoro-2-phosphonylmethoxypropyl)derivatives of purine and pyrimidine heterocyclic basis,their preparation and use | |
ES2061609T3 (en) | 2 ', 3'-DIDEOXI-2'-FLUORO-NUCLEOSIDES. | |
DE3780016D1 (en) | PHARMACEUTICAL PREPARATION WITH 3'-DESOXYTHYMIDIN-2'-EN (3'-DESOXY-2 ', 3'-DIDEHYDROTHYMIDINE) FOR TREATING PATIENTS WITH RETROVIRAL INFECTIONS. | |
DK422589A (en) | PHARMACEUTICAL PREPARATION FOR TREATMENT OF IMMUNE DEFECTIVE CONDITIONS | |
DK538888A (en) | USE OF CASTANOSPERMINESTERS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION | |
TW371662B (en) | Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives | |
ATE132163T1 (en) | NEW POLYPEPTIDES AND ANTI-HIV DRUGS PRODUCED THEM | |
IT8621397A0 (en) | PYRROLIDIN-2-ONE DERIVATIVES NOOTROPHIC ADAPTIVITY. | |
ATE108335T1 (en) | KIT OR COMPOSITION FOR THE PREVENTION OR TREATMENT OF HIV-1 INFECTION. | |
IT1225262B (en) | METHOD FOR THE AWARENESS OF SMALL ANIMALS TO VIRUS INFECTION OF HUMAN IMMUNODEFICIENCY (HIV) | |
ES2066897T3 (en) | 5,11-DIHYDRO-6H-PIRIDO (2,3-B) (1,4) BENZODIAZEPIN-6-ONAS AND -TIONAS AND THEIR USE IN THE PREVENTION OR TREATMENT OF AIDS. | |
ATE87482T1 (en) | PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CEREBRAL PSYCHO-ORGANIC SYNDROMES. | |
PT99962A (en) | USING ANTI-DEPRESSING MEDICINE | |
IT8622051A0 (en) | PHARMACEUTICAL COMPOSITIONS HEALING ADAPTIVITY. | |
DK469487A (en) | PHARMACEUTICAL TREATMENT MEDICINE | |
FI862413A0 (en) | TORKNINGSGRUPP MED ENKEL VIRA FOER PAPPERSMASKIN. | |
FI862412A (en) | ANORDNING FOER OMRAODET AV DRAGET MED ANKEL VIRA I FLERCYLINDERTORKEN AV EN PAPPERSMASKIN. | |
ATE79529T1 (en) | DEVICE FOR THE STIMULATION OF LIMB ARRANGEMENTS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |